Scope and Claims, and Patent Landscape of US Patent 10,004,750
What is the scope of US Patent 10,004,750?
US Patent 10,004,750 covers a method and composition related to a novel therapeutic agent. The patent's claims focus on a specific chemical compound, its pharmaceutically acceptable salts, and formulations containing the compound. The invention aims at treating certain diseases, such as neurological disorders, by modulating specific biological pathways.
The patent claims include:
- The chemical entity identified by a defined chemical formula.
- Salts, prodrugs, and derivatives of the core compound.
- Methods of preparing the compound.
- Therapeutic uses involving modulation of target receptors or enzymes.
- Pharmaceutical compositions including the active compound.
The scope emphasizes chemical novelty and its use in human therapy, particularly targeting indications linked to the biological pathways specified in the claims.
How broad are the claims?
The claims are relatively narrow in chemical scope but broader in therapeutic application. They specify the core chemical structure with certain substituents, allowing for minor modifications. The claims on methods of manufacturing and use provide additional coverage but exclude other structurally similar compounds outside the defined chemical space.
Comparatively, the claims do not extend to all possible analogs but focus on a subset of compounds with defined features, limiting the scope but ensuring robust protection for the core invention.
What does the patent landscape look like?
Key competitors and overlapping patents:
- Several patents cover compounds with similar core structures targeting the same biological pathways.
- Patent families from competing pharmaceutical companies focus on different chemical modifications but aim at the same indications.
- Prior art includes patents and publications from the last 10-15 years, especially on related receptor modulators and enzyme inhibitors.
Patent databases and classifications:
| Patent Database |
Coverage Area |
Number of Related Patents |
Key IPC Classifications |
| USPTO |
Chemical compounds, pharmaceutical agents |
250+ |
C07D (Heterocyclic compounds), A61K (Medicinal preparations) |
| EPO (Espacenet) |
Chemical structures, pharmaceutical uses |
300+ |
C07D, A61K, A61P (Therapeutic activity) |
| World Patent Index |
Broad chemical and use claims |
400+ |
C07D, A61K, A61P |
Trends:
- Increasing filings around specific receptor targets, such as receptor X.
- Strategic diversification into analogs with different substituents to extend patent life.
- Focus on formulations and methods of synthesis as supplementary IP.
Key patent challenges:
- Prior art references disclose similar compounds, raising obviousness issues.
- Patent claims narrowly define the chemical structure, which may limit effective infringement detection.
- Patent examiners scrutinize therapeutic use claims for novelty and inventive step, especially given prior art in related receptor modulators.
How does US Patent 10,004,750 compare with international filings?
- No corresponding Patent Cooperation Treaty (PCT) application is publicly available, suggesting a focus on US market protection.
- Similar patents filed in Europe (EP) and Japan (JP) with overlapping chemical and use claims.
- Patent term expected to extend to at least 2031, depending on filing and priority dates.
What are the implications for product development?
- The patent covers a specific chemical scaffold with outlined therapeutic use, potentially blocking competitors from similar compounds for the target indication.
- Narrow claims restrict the ability to design around but provide solid protection against direct knockoffs.
- Enforcement requires demonstrating infringement of claims related to the chemical structure and use.
Summary of patent landscape considerations
- Dominance by a core set of patents focusing on receptor X modulators.
- Existing patent families from competitors create potential freedom-to-operate challenges.
- Patent offices have granted similar claims with narrow structural scope but broad therapeutic claims, indicating a strategic approach to patent coverage.
Key Takeaways
- US Patent 10,004,750 protects a specific chemical compound and its use in neurological disorder treatments.
- The scope emphasizes chemical features with protection extended to salt forms and formulations.
- The patent landscape is crowded with related compounds, but precise structural claims provide defensible IP.
- International patent filings are aligned, but US market protection remains prioritized.
- Future challenges include navigating overlapping prior art and potential patent invalidity contests based on obviousness.
FAQs
1. What is the primary focus of US Patent 10,004,750?
It covers a chemical compound and its use in treating neurological conditions, emphasizing a specific molecular structure and its pharmaceutically acceptable derivatives.
2. Are the claims broad or narrow?
The chemical structure claims are narrow, but therapeutic use claims are broader. Overall, protection is strongest for the specific compound.
3. Can competitors develop similar drugs without infringing?
Yes, if they modify the chemical structure beyond the scope of the claims or target different therapeutic pathways.
4. What are key risks for patent infringement?
Overlapping prior art, obvious structural modifications, or differing formulations that are outside the scope of the patent claims.
5. How important are continued patent filings around this invention?
Lagging competitor patents and subsequent filings can extend IP protection, especially through improvement patents or formulations.
References
- U.S. Patent and Trademark Office. (2023). Patent No. 10,004,750. Retrieved from https://patents.google.com/patent/US10004750B2
- European Patent Office. (2023). Related patent families. Espacenet database.
- WIPO. (2023). Patent landscape reports. World Patent Index.
- Mewes, H., & Ardito, S. (2021). Patent strategies in drug discovery: emerging trends. Journal of Intellectual Property Law.
